Refractory Lupus Nephritis clinical trials

Explore recruiting refractory lupus nephritis clinical trials.

Recruiting refractory lupus nephritis studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Refractory Lupus Nephritis trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

Phase I-IIa, national, multicenter, clinical trial to evaluate the safety and preliminary efficacy of CAR-T CD19 therapy in patients with refractory lupus nephritis.

Spain

Phase I and Phase II (Integrated)- Other EU CTIS Study details

A Phase 2, open-label study to evaluate the efficacy and safety of rapcabtagene autoleucel in patients with active, refractory systemic lupus erythematosus (SLE), or active, refractory lupus nephritis (LN).

France, Spain, Italy, Netherlands, Germany, Czechia +7 more

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 1/2, Open-Label, Multicenter Study of KYV-101, an Autologous Fully-Human Anti-CD19 Chimeric Antigen Receptor T-Cell (CD19 CAR T) Therapy, in Subjects with Refractory Lupus Nephritis (KYSA-3)

Germany

Phase I and Phase II (Integrated)- First administration to humans EU CTIS Study details

Refractory Lupus Nephritis trials by city

Refractory Lupus Nephritis in Toronto Refractory Lupus Nephritis in Vancouver Refractory Lupus Nephritis in Montreal Refractory Lupus Nephritis in Calgary Refractory Lupus Nephritis in Edmonton Refractory Lupus Nephritis in Ottawa Refractory Lupus Nephritis in Winnipeg Refractory Lupus Nephritis in Quebec City Refractory Lupus Nephritis in Hamilton Refractory Lupus Nephritis in Kitchener Refractory Lupus Nephritis in London Refractory Lupus Nephritis in Halifax Refractory Lupus Nephritis in New York Refractory Lupus Nephritis in Los Angeles Refractory Lupus Nephritis in Chicago Refractory Lupus Nephritis in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease